BAS Crosses Critical Technical Indicator

In trading on Thursday, shares of Basic Energy Services Inc (BAS) entered into oversold territory, changing hands as low as $6.96 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In the case of Basic Energy Services Inc, the RSI reading has hit 29.5 — by comparison, the universe of energy stocks covered by Energy Stock Channel currently has an average RSI of 44.3, the RSI of WTI Crude Oil is at 53.0, and the RSI of Henry Hub Natural Gas is presently 53.9.

START SLIDESHOW:
Click here to find out which 9 other oversold energy stocks you need to know about »

A bullish investor could look at BAS's 29.5 reading as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.

Looking at a chart of one year performance (below), BAS's low point in its 52 week range is $5.00 per share, with $29.84 as the 52 week high point — that compares with a last trade of $7.12. Basic Energy Services Inc shares are currently trading down about 4.2% on the day.

Basic Energy Services Inc 1 Year Performance Chart

According to the ETF Finder at ETF Channel, BAS makes up 1.15% of the Guggenheim S&P SmallCap 600 Pure Value ETF ( RZV) which is trading higher by about 0.3% on the day Thursday.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says